FOR CLINICIANS
Resources for referring clinicians
Concise, guideline-based summaries for prescribing and monitoring hormone therapies, with links to the primary evidence.
Written and reviewed by Farhan Tahir, MD
GRAND ROUNDS
Research updates, appraised for practice
New trials and guideline changes in menopause, testosterone and thyroid care, with evidence levels and what they mean for patients.
3 GUIDES
Prescribing
Prescribing
Prescribing menopausal hormone therapy after the label change
A practical framework for systemic HT: who benefits, which formulation, and what changed on the label.
Read the guide →
Prescribing
Non-hormonal options for vasomotor symptoms
Evidence and monitoring for fezolinetant, elinzanetant, paroxetine and other non-hormonal therapies.
Read the guide →
Prescribing
Hot flashes and GSM in breast cancer survivors
Managing vasomotor and genitourinary symptoms safely alongside oncology care.
Read the guide →
3 GUIDES
Diagnosis & monitoring
Diagnosis & monitoring
Diagnosing perimenopause without labs
Age and cycle pattern make the diagnosis after 45. When labs help, and the mimics to exclude.
Read the guide →
Diagnosis & monitoring
Testosterone deficiency: workup and monitoring
A stepwise workup and monitoring schedule aligned with Endocrine Society and AUA guidance.
Read the guide →
Diagnosis & monitoring
Subclinical hypothyroidism: when to treat
Most adults with a mildly raised TSH do not benefit from levothyroxine. Here's who might.
Read the guide →